Adaptive Biotechnologies Corp (ADPT) stock is lower by -10.35% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ADPT stock a score of 30 out of a possible 100.
That rank is influenced by a short-term technical score of 2. ADPT's rank also includes a long-term technical score of 5. The fundamental score for ADPT is 82. In addition to the average rating from Wall Street analysts, ADPT stock has a mean target price of 60.8. This means analysts expect the stock to add 90.66% over the next 12 months.
What's Happening with ADPT Stock Today
Adaptive Biotechnologies Corp (ADPT) stock is down -3.11% while the S&P 500 has risen 1.04% as of 11:36 AM on Thursday, May 13. ADPT is lower by -$1.02 from the previous closing price of $32.91 on volume of 745,907 shares. Over the past year the S&P 500 is higher by 45.58% while ADPT is lower by -10.35%. ADPT lost -$1.15 per share in the over the last 12 months.